← Leaderboards
Anantha Harijith
University Of Illinois At Chicago
$1,513,057
Attributed
$1,513,057
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $323.8K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,513,057 · 1
By mechanism
R01$1,513,057 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Asrar B. Malik$58,182,625
- Orly Lazarov$21,889,643
- Bellur S Prabhakar$8,432,775
- Salman R Khetani$7,662,172
- Kamran Avanaki$3,821,326
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAffectAdultAirway RemodelingAlveolarAnimal ModelBaseAirway HyperresponsivenessBronchopulmonary DysplasiaCaringCellsChildhoodChronicClinical TrialsCognitionCognitive FunctionCollagenBrainComparativeCrosslinkDependenceDrug KineticsEffective TherapyExposure To
Grant awards (5)
Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling$281,534
R01 · FY2022 · HD · contact PI
Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling$281,534
R01 · FY2021 · HD · contact PI
Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling$302,393
R01 · FY2020 · HD · contact PI
Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling$323,798
R01 · FY2019 · HD · contact PI
Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling$323,798
R01 · FY2018 · HD · contact PI